Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8827 |
High Similarity |
NPD3882 |
Suspended |
0.882 |
High Similarity |
NPD2801 |
Approved |
0.8734 |
High Similarity |
NPD1512 |
Approved |
0.8642 |
High Similarity |
NPD1934 |
Approved |
0.8608 |
High Similarity |
NPD1511 |
Approved |
0.8571 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD6166 |
Phase 2 |
0.8471 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8434 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8402 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8393 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8364 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8343 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8304 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8263 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8229 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8208 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8204 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8144 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8114 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8068 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8059 |
Intermediate Similarity |
NPD919 |
Approved |
0.8 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7965 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7964 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7962 |
Intermediate Similarity |
NPD943 |
Approved |
0.7955 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.795 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.791 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7898 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7895 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7888 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7888 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7882 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7879 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7865 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7857 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7824 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7818 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7805 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7791 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7683 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7679 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7674 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7636 |
Intermediate Similarity |
NPD3750 |
Approved |
0.763 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7627 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7607 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7602 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7596 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7576 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7574 |
Intermediate Similarity |
NPD920 |
Approved |
0.7571 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD2532 |
Approved |
0.756 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD2533 |
Approved |
0.756 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7546 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7487 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7473 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7471 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7469 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7459 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7458 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7456 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7443 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.744 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7416 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7396 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7362 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7349 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7349 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7321 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7297 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7297 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7262 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7257 |
Intermediate Similarity |
NPD37 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7232 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7232 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7186 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7186 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7186 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7186 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7178 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7178 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7126 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7107 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD9494 |
Approved |
0.709 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7081 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7071 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7049 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7048 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7041 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7039 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7033 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7033 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7033 |
Intermediate Similarity |
NPD5710 |
Approved |
0.702 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.702 |
Intermediate Similarity |
NPD7697 |
Approved |
0.702 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7018 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7015 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6973 |
Remote Similarity |
NPD2163 |
Approved |
0.6973 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD7907 |
Approved |
0.697 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6965 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD6534 |
Approved |
0.6959 |
Remote Similarity |
NPD6535 |
Approved |
0.6957 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.6952 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6951 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6946 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6937 |
Remote Similarity |
NPD1201 |
Approved |
0.6935 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6915 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6909 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6902 |
Remote Similarity |
NPD5242 |
Approved |
0.6897 |
Remote Similarity |
NPD7874 |
Approved |
0.6897 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD6280 |
Approved |
0.6872 |
Remote Similarity |
NPD6279 |
Approved |
0.6867 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6867 |
Remote Similarity |
NPD411 |
Approved |
0.6867 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6863 |
Remote Similarity |
NPD7801 |
Approved |
0.6853 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6853 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6834 |
Remote Similarity |
NPD3452 |
Approved |
0.6834 |
Remote Similarity |
NPD3450 |
Approved |
0.6834 |
Remote Similarity |
NPD2493 |
Approved |
0.6834 |
Remote Similarity |
NPD2494 |
Approved |
0.6832 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6832 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6829 |
Remote Similarity |
NPD2798 |
Approved |
0.6805 |
Remote Similarity |
NPD6651 |
Approved |
0.68 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6798 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6796 |
Remote Similarity |
NPD4288 |
Approved |
0.6791 |
Remote Similarity |
NPD7177 |
Discontinued |
0.679 |
Remote Similarity |
NPD1608 |
Approved |
0.679 |
Remote Similarity |
NPD9717 |
Approved |
0.6789
|
Remote Similarity |
NPD7549 |
Discontinued |